drugset / Trial / NCT00957385
Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if Revlimid will help maintain patients with acute myeloid leukemia in remission.
Timeline
- Start
- 2008-06
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lenalidomide | Other / unclassified | 10 mg | Oral |